SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending following reports of a potential $53 billion buyout offer from Stripe and Advent International, sparking a debate among investors over whether the bid represents a fair valuation or an opportunistic lowball attempt. The community is actively discussing the potential for a bidding war, the company's long-term cash flow strength, and the possibility of a short squeeze as traders weigh whether to hold for a higher premium or exit their positions.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is currently driving significant market conversation due to its high-profile Nasdaq ADR debut and its critical role as a primary supplier of HBM for AI hardware. The community is actively debating the stock's volatility and valuation, with many discussing the impact of newly launched leveraged ETFs and ongoing AI infrastructure spending.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing heightened volatility as investors debate the impact of hyperscaler competition and persistent insider selling despite a massive $99 billion contracted revenue backlog. While bulls point to the company's critical role in AI infrastructure and institutional accumulation, bears remain focused on the heavy selling pressure and uncertainty regarding future profitability in a crowded market.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to strong quarterly earnings that exceeded estimates, a raised full-year sales outlook, and confirmed ongoing demand for its advanced lithography technology from major foundries. The investment community is actively discussing the company's critical role in the AI infrastructure supply chain and the long-term capacity expansion plans aimed at meeting persistent semiconductor demand.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley shares are surging following a strong fourth-quarter report that featured an earnings beat driven by a 47% spike in investment banking fees and record revenue in its wealth management division. The financial community is actively discussing the bank's ability to capitalize on the rebounding IPO and M&A market, reinforcing bullish sentiment as the stock eyes new all-time highs.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently in the spotlight following strong Q2 earnings that surpassed market expectations, bolstered by growth in its Innovative Medicine and MedTech segments. While the company raised its full-year guidance, the stock has experienced recent volatility as the community debates the impact of potential patent losses and the broader rotation of capital out of healthcare back into the tech sector.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as a primary play on AI hardware and silicon carbide demand, with investors focused on record-breaking bookings and aggressive fiscal revenue guidance that significantly outpaces analyst expectations. Despite active community debate over its valuation and the lack of specific dollar amounts in recent order announcements, bulls are pointing to the company's critical role in wafer-level burn-in for AI processors and photonics as evidence of a structural growth cycle.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is trending following the FDA approval of REVTORPYK for HR+/HER2- PIK3CA wild-type advanced breast cancer, a major milestone marking its transition into a commercial-stage oncology company. The community is actively discussing the stock's significant short interest, the potential for an eventual buyout by big pharma, and the expectation that institutional interest will rise as analysts update their valuation models to reflect the drug's commercial launch potential.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is experiencing significant market volatility and heavy selling pressure as investors react to a dividend cut aimed at deleveraging the company and a downward revision of future earnings guidance. The community is sharply divided, with many debating the merits of holding the stock for its defensive, high-yield value in a challenging grocery environment versus concerns that the dividend cut signals deeper structural issues and a lack of near-term growth catalysts.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently a focal point for investors as it faces intense downward pressure driven by sector rotation away from medical devices toward high-momentum AI stocks, coupled with concerns regarding reduced growth expectations for its Watchman franchise. While the community is actively debating whether the stock represents a deep-value opportunity at multi-year lows or a structural trap, many are watching the upcoming conclusion of the company's $2 billion accelerated share repurchase program as a potential catalyst for stabilization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DCI
Price: $84.98 (-0.71%)
Trend: Bearish
Market Bias (7D): Sideways ⚖️
Expected Range: ±0.60%
RSI: 45.6 | Momentum: Moderate
Volume: -58.9% vs avg
Volatility: 1.45%
Support: $83.75 | Resistance: $90.73

Tools used: https://www.trade-ideas.com
Code: INTERSTOCK25

Trade Ideas: Real-time AI stock scanning, automated trades, entry/exit signals & trade alerts. Manage your portfolio, mitigate risk, backtest, & analyze markets

Trade-ideas

Trade Ideas: AI-Driven Stock Scanning & Charting Platform

StockTwits Web

Donaldson Co. Inc.


Price: $84.98 (-0.71%)
Trend: Bearish
Market Bias (7D): Sideways ⚖️
Expected Range: ±0.60%
RSI: 45.6 | Momentum: Moderate
Volume: -58.9% vs avg
Volatility: 1.45%
Support: $83.75 | Resistance: $90.73

Tools used: 